Therapeutic compositions for treatment of corneal disorders

Details for Australian Patent Application No. 2010203425 (hide)

Owner The Schepens Eye Research Institute, Inc.

Inventors Dana, Reza; Dastjerdi, Mohammed; Chauhan, Sunil

Agent Freehills

Pub. Number AU-A-2010203425

PCT Pub. Number WO2010/081091

Priority 61/143,561 09.01.09 US

Filing date 11 January 2010

Wipo publication date 15 July 2010

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 27/02 (2006.01) Drugs for disorders of the senses

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/081091 Priority application(s): WO2010/081091

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010203427-Intraocular lenses and methods of accounting for capsule size variability and post-implant changes in the eye

2010203416-Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections